Literature DB >> 15957514

Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study.

J Liepert1, D Mingers, C Heesen, T Bäumer, C Weiller.   

Abstract

We investigated electrophysiological correlates of fatigue in patients with multiple sclerosis (MS). Transcranial magnetic stimulation (TMS) was used to explore motor excitability in three groups of subjects: MS patients with fatigue (MS-F), MS patients without fatigue (MS-NF) and healthy control subjects. All participants had to perform a fatiguing hand-grip exercise. TMS was performed prior to and after the exercise. Prior to the motor task, MS-F patients had less inhibition in the primary motor cortex compared to both other groups. Postexercise, intracortical inhibition was still reduced in the MS-F patients compared to the MS-NF patients. In MS-F patients the postexercise time interval for normalization of the motor threshold was correlated with the fatigue severity. We conclude that MS patients with fatigue have an impairment of inhibitory circuits in their primary motor cortex. The results also indicate that fatigue severity is associated with an exercise-induced reduction of membrane excitability.

Entities:  

Mesh:

Year:  2005        PMID: 15957514     DOI: 10.1191/1352458505ms1163oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  37 in total

1.  Post-stroke fatigue: a deficit in corticomotor excitability?

Authors:  Annapoorna Kuppuswamy; Ella V Clark; Isobel F Turner; John C Rothwell; Nick S Ward
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

2.  Motor evoked potential depression following repetitive central motor initiation.

Authors:  Benzi M Kluger; Candace Palmer; Johanna T Shattuck; William J Triggs
Journal:  Exp Brain Res       Date:  2011-12-01       Impact factor: 1.972

3.  Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.

Authors:  I Specogna; F Casagrande; A Lorusso; M Catalan; A Gorian; L Zugna; R Longo; M Zorzon; M Naccarato; G Pizzolato; M Ukmar; M A Cova
Journal:  Radiol Med       Date:  2012-06-22       Impact factor: 3.469

4.  Cortical excitability changes over time in progressive multiple sclerosis.

Authors:  Samar S Ayache; Alain Créange; Wassim H Farhat; Hela G Zouari; Catherine Lesage; Ulrich Palm; Mohammed Abdellaoui; Jean-Pascal Lefaucheur
Journal:  Funct Neurol       Date:  2015 Oct-Dec

5.  Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  A Conte; D Lenzi; V Frasca; F Gilio; E Giacomelli; M Gabriele; C Marini Bettolo; E Iacovelli; P Pantano; C Pozzilli; M Inghilleri
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

6.  Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation.

Authors:  Franca Tecchio; Andrea Cancelli; Carlo Cottone; Giancarlo Zito; Patrizio Pasqualetti; Anna Ghazaryan; Paolo Maria Rossini; Maria Maddalena Filippi
Journal:  J Neurol       Date:  2014-05-23       Impact factor: 4.849

7.  Objective assessment of motor fatigue in multiple sclerosis: the Fatigue index Kliniken Schmieder (FKS).

Authors:  Aida Sehle; Manfred Vieten; Simon Sailer; Annegret Mündermann; Christian Dettmers
Journal:  J Neurol       Date:  2014-06-22       Impact factor: 4.849

8.  A reduced somatosensory gating response in individuals with multiple sclerosis is related to walking impairment.

Authors:  David J Arpin; James E Gehringer; Tony W Wilson; Max J Kurz
Journal:  J Neurophysiol       Date:  2017-07-19       Impact factor: 2.714

9.  Distribution of parvalbumin and calretinin immunoreactive interneurons in motor cortex from multiple sclerosis post-mortem tissue.

Authors:  Robert J Clements; Jennifer McDonough; Ernest J Freeman
Journal:  Exp Brain Res       Date:  2008-02-23       Impact factor: 1.972

10.  The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis.

Authors:  Nicole M Stroud; Clare L Minahan
Journal:  Health Qual Life Outcomes       Date:  2009-07-20       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.